Clinical trial
A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
NCT01576887
Study timeline
Study start (actual)2012-07-31Date precision: day
Registry last updated2025-05-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
End-Stage Renal Diseaseunresolved
Type 2 Diabetes Mellitusunresolved
Interventions
PlaceboDRUG
Sponsors & collaborators
Biogenlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01576887 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.